Freedom (FRHC) had the highest return between January 1, 2017 and May 31, 2018 by a mid-cap US stock, returning 5,172.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Freedom (FRHC) | 1/1/2017 - 5/31/2018 | 5,172.73% |
Madrigal Pharmaceuticals (MDGL) | 1/1/2017 - 5/31/2018 | 1,676.66% |
Viking Therapeutics (VKTX) | 1/1/2017 - 5/31/2018 | 732.5% |
Arrowhead Pharmaceuticals (ARWR) | 1/1/2017 - 5/31/2018 | 587.18% |
Enphase Energy (ENPH) | 1/1/2017 - 5/31/2018 | 461.76% |
Autohome (ATHM) | 1/1/2017 - 5/31/2018 | 346.78% |
Vericel Corp Ord (VCEL) | 1/1/2017 - 5/31/2018 | 340.98% |
Light & Wonder (LNW) | 1/1/2017 - 5/31/2018 | 316.14% |
GDS (GDS) | 1/1/2017 - 5/31/2018 | 313.67% |
Novocure (NVCR) | 1/1/2017 - 5/31/2018 | 295.6% |
Catalyst Pharmaceuticals (CPRX) | 1/1/2017 - 5/31/2018 | 269.23% |
Ringcentral (RNG) | 1/1/2017 - 5/31/2018 | 260.71% |
Ascendis Pharma A-S (ASND) | 1/1/2017 - 5/31/2018 | 260.64% |
TAL Education (TAL) | 1/1/2017 - 5/31/2018 | 260.27% |
Huazhu (HTHT) | 1/1/2017 - 5/31/2018 | 241.86% |
Amicus Therapeutics (FOLD) | 1/1/2017 - 5/31/2018 | 232.68% |
Crispr Therapeutics (CRSP) | 1/1/2017 - 5/31/2018 | 228.14% |
Warrior Met Coal (HCC) | 1/1/2017 - 5/31/2018 | 220.17% |
RH (RH) | 1/1/2017 - 5/31/2018 | 217.31% |
PTC Therapeutics (PTCT) | 1/1/2017 - 5/31/2018 | 206.51% |
Novanta (NOVT) | 1/1/2017 - 5/31/2018 | 205.18% |
Blueprint Medicines (BPMC) | 1/1/2017 - 5/31/2018 | 196.79% |
YY Inc Class A (YY) | 1/1/2017 - 5/31/2018 | 191.32% |
Quidel (QDEL) | 1/1/2017 - 5/31/2018 | 188.54% |
Varonis Systems (VRNS) | 1/1/2017 - 5/31/2018 | 188.13% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
